Cargando…
Selective C‐reactive protein apheresis for Covid‐19 patients suffering from organ damage
Autores principales: | Kayser, Stefan, Kunze, Rudolf, Sheriff, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300911/ https://www.ncbi.nlm.nih.gov/pubmed/32501607 http://dx.doi.org/10.1111/1744-9987.13532 |
Ejemplares similares
-
Selective Apheresis of C-Reactive Protein for Treatment of Indications with Elevated CRP Concentrations
por: Kayser, Stefan, et al.
Publicado: (2020) -
Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons
por: Torzewski, Jan, et al.
Publicado: (2022) -
Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis
por: Torzewski, Jan, et al.
Publicado: (2021) -
First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 Infection
por: Torzewski, Jan, et al.
Publicado: (2020) -
Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction—Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study
por: Skarabis, Horst, et al.
Publicado: (2022)